RSV A, RSV B RT-PCR

RSV A, RSV B RT-PCR

GSD NovaType IV SARS-CoV-2 (1x96)

GSD NovaType IV SARS-CoV-2 (1x96)

GSD NovaPrime® TSP SARS-CoV-2 (COVID 19) 1x96

The GSD NovaPrime® TSP SARS-CoV-2 (COVID-19) is intended for the qualitative determination of SARS-CoV-2 genomic RNA in several respiratory sample types to aid in the diagnosis of COVID-19. This product represents an improvement in comparison to its former version GSD NovaPrime® SARS-CoV-2, with less sample volume required.

 

Contact us

The GSD NovaPrime® TSP SARS-CoV-2 RT-PCR is intended for the qualitative determination of SARS-CoV-2 genomic RNA extracted from human upper respiratory (nasal wash/swab, nasopharyngeal swab, oropharyngeal swab) specimen types collected from individuals suspected of respiratory viral infection. The analytic sensitivity shows a limit of detection of 3 copies/reaction.

This product represents an improvement in comparison to its former version GSD NovaPrime® SARS-CoV-2.

Key Benefits

  • • Specimen types:nasopharyngeal wash/swab, nasal wash/swab, and oropharyngeal swab
  • • Less sample volume required
  • • Extraction/inhibition and positive control included
  • • Approximately 1 hour turnaround time
  • • Excellent performance with higher sensitivity
  • • CE-IVD marked
More Information
SKU PCOV6111
No. of tests 96
Time to Result Approximately 1 hour
PCR cycler platforms ABI Prism® 7500 SDS (Applied BiosystemsTM), ABI Prism® 7500 Fast SDS (Applied BiosystemsTM) , AriaMx™ (Agilent Technologies), AriaDx™ (Agilent Technologies), CFX96 Touch™ (Bio-Rad), LightCycler® 480 II (Roche), QuantStudio™ 5 (Applied BiosystemsTM)
Kit components Polymerase, reverse transcriptase with RNase inhibitor, Primer-Probe-Mix, Extraction Control, Positive Control, Nuclease Free Water

Test Instructions